Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133929) titled 'A prospective clinical study of individualized chemotherapy regimens for malignant ovarian germ cell tumors based on risk stratification' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Malignant ovarian germ cell tumor
Intervention:
Intermediate-risk group: 3-day PEB regimen (weekly):None
Low-risk group: 3-day PEB regimen (per course):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-13
Target Sample Size: Intermediate-risk group: 3-day PEB regimen (weekly):60;Low-risk group: 3...